These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 1356560
1. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs. Cambridge D, Whiting MV, Butterfield LJ, Allan G. Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560 [Abstract] [Full Text] [Related]
2. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties. Cambridge D, Whiting MV, Allan G. Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874 [Abstract] [Full Text] [Related]
3. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity. Ajayi AA, Sofowora GG, Adigun AQ, Asiyanbola B. Ethn Dis; 2003 Jan; 13(1):71-9. PubMed ID: 12723015 [Abstract] [Full Text] [Related]
4. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. Squire IB, MacFayden RJ, Reid JL, Devlin A, Lees KR. J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935 [Abstract] [Full Text] [Related]
5. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan. Hajj-Ali AF, Wong PC. J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389 [Abstract] [Full Text] [Related]
6. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats. Schiffrin EL, Gutkowska J, Thibault G, Genest J. Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602 [Abstract] [Full Text] [Related]
9. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? Schilders JE, Wu H, Boomsma F, van den Meiracker AH, Danser AH. Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603 [Abstract] [Full Text] [Related]
12. Effects of ACE inhibition and beta-blockade on collagen remodelling in the heart of Bio 14.6 hamsters. Mansoor AM, Honda M, Kuramochi T, Tanaka K, Morioka S, Takabatake T. Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):43-9. PubMed ID: 8713495 [Abstract] [Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. Czendlik CH, Sioufi A, Preiswerk G, Howald H. Eur J Clin Pharmacol; 1997 Jan; 52(6):451-9. PubMed ID: 9342580 [Abstract] [Full Text] [Related]
19. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension. Teeuw AH, Leenen FH, Geyskes GG, Boer P. Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678 [Abstract] [Full Text] [Related]